The Changing Landscape and Advances in the Treatment of Multiple Myeloma (APAC)
We will outline the overview of the current treatments available for multiple myeloma including the loss of market exclusivity for key products in the space. We will also discuss the latest research and innovations that are driving new treatments to help improve patient outcomes in multiple myeloma, including the debate over the risk of secondary malignancies from cell therapy.